Aktie A003060 APROGEN BIOLOGICS INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Aprogen Biologics Inc.

Aktien

A003060

KR7003060001

A003060

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
1 631 KRW +5,84 % Intraday Chart für Aprogen Biologics Inc. +5,16 % -43,76 %
13.03. Aprogen Biologics Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Aprogen Biologics Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aprogen Biologics Inc.(KOSE:A003060) dropped from S&P Global BMI Index
Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aprogen Biologics Inc. announced that it has received KRW 20 billion in funding from Aprogen, Inc.
Aprogen Biologics Inc. announced that it expects to receive KRW 20 billion in funding from Aprogen, Inc.
Aprogen Biologics Inc. announced that it has received KRW 40 billion in funding
Aprogen Biologics Inc. announced that it expects to receive KRW 40 billion in funding
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.
Aprogen pharmaceuticals,Inc. completed the acquisition of Aprogen Biologics Inc. from Aprogen, Inc.
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Aprogen Pharmaceuticals to Raise $35.1 Million Through Stock Issuance
Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A003060 Aktie
  4. Nachrichten Aprogen Biologics Inc.
  5. Andere Sprachen